PEX11B expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 2.40918396343659E-14 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
2.38630004645302E-09 |
Normal-vs-Stage2 |
9.75119999968577E-07 |
Normal-vs-Stage3 |
1.33226762955019E-15 |
Normal-vs-Stage4 |
1.62536650805123E-12 |
Stage1-vs-Stage2 |
3.790200E-01 |
Stage1-vs-Stage3 |
2.211100E-04 |
Stage1-vs-Stage4 |
3.814800E-04 |
Stage2-vs-Stage3 |
9.934100E-02 |
Stage2-vs-Stage4 |
8.908200E-02 |
Stage3-vs-Stage4 |
8.053600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
1.69175784492381E-12 |
Normal-vs-AfricanAmerican |
1.32940003449988E-09 |
Normal-vs-Asian |
4.069900E-02 |
Caucasian-vs-AfricanAmerican |
5.099800E-01 |
Caucasian-vs-Asian |
4.305000E-01 |
AfricanAmerican-vs-Asian |
3.206600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
<1E-12 |
Normal-vs-Female |
6.2838000358667E-09 |
Male-vs-Female |
1.735500E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
9.62120000003175E-07 |
Normal-vs-Age(41-60Yrs) |
2.49111842265393E-12 |
Normal-vs-Age(61-80Yrs) |
1.62569957495862E-12 |
Normal-vs-Age(81-100Yrs) |
1.915860E-02 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.673600E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.863600E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.693000E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.078600E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.058200E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.197400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
1.268220E-01 |
Normal-vs-Grade 2 |
1.56889999880505E-08 |
Normal-vs-Grade 3 |
1.64046554118613E-12 |
Normal-vs-Grade 4 |
1.62447832963153E-12 |
Grade 1-vs-Grade 2 |
1.839170E-01 |
Grade 1-vs-Grade 3 |
1.688280E-02 |
Grade 1-vs-Grade 4 |
4.20500000000157E-05 |
Grade 2-vs-Grade 3 |
8.180400E-03 |
Grade 2-vs-Grade 4 |
1.59909999686292E-08 |
Grade 3-vs-Grade 4 |
5.807100E-04 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
4.41110000000133E-05 |
Normal-vs-ccB subtype |
1.62447832963153E-12 |
ccA subtype-vs-ccB subtype |
7.32747196252603E-15 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
7.76489983422834E-13 |
Normal-vs-N1 |
3.01260000001857E-06 |
N0-vs-N1 |
4.621200E-01 |
|
|